TNFi not linked to increased cancer recurrence in RA patients
(HealthDay)—For patients with rheumatoid arthritis (RA), treatment with tumor necrosis factor inhibitors (TNFi) is not associated with increased risk for cancer recurrence, according to a study published online Aug. 14 ...
Aug 24, 2018
0
0